Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration
Continue Reading Does Section 1782 Apply to Discovery in Private International Commercial Arbitration Proceedings?